Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
China · Delayed Price · Currency is CNY 17.00
+1.07 (6.72%)
Sep 14, 2026, 3:00 PM CST
SHA:605369 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,743 | 4,107 | 4,390 | 6,286 | 11,895 | 16,136 | |
Market Cap Growth | -15.08% | -6.45% | -30.17% | -47.15% | -26.28% | 249.25% |
Enterprise Value | 3,292 | 3,712 | 3,978 | 5,789 | 11,150 | 15,414 |
Last Close Price | 17.00 | 18.48 | 19.57 | 27.31 | 50.92 | 68.23 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 68.14 | 79.73 | 25.58 | 57.61 | 36.48 | 51.89 |
Forward PE | 19.83 | 26.89 | 17.39 | 26.55 | 25.25 | 45.56 |
PS Ratio | 3.21 | 3.62 | 3.94 | 6.45 | 8.10 | 13.51 |
PB Ratio | 2.18 | 2.41 | 2.56 | 3.84 | 7.47 | 11.63 |
P/TBV Ratio | 2.69 | 3.00 | 3.25 | 4.71 | 7.86 | 12.35 |
P/FCF Ratio | 23.05 | 28.85 | 43.56 | 98.89 | 107.58 | 165.62 |
P/OCF Ratio | 12.72 | 16.17 | 20.87 | 33.91 | 42.07 | 43.26 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.82 | 3.27 | 3.57 | 5.94 | 7.59 | 12.91 |
EV/EBITDA Ratio | 16.30 | 20.12 | 16.06 | 29.92 | 30.56 | 43.11 |
EV/EBIT Ratio | 30.80 | 38.17 | 25.80 | 52.87 | 34.39 | 45.87 |
EV/FCF Ratio | 20.27 | 26.07 | 39.48 | 91.06 | 100.84 | 158.21 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.14 | 0.10 | 0.03 | 0.02 | 0 | 0.00 |
Debt / EBITDA Ratio | 1.17 | 0.83 | 0.21 | 0.18 | 0.00 | 0.00 |
Debt / FCF Ratio | 1.46 | 1.16 | 0.52 | 0.56 | 0.00 | 0.01 |
Net Debt / Equity Ratio | -0.27 | -0.27 | -0.23 | -0.25 | -0.47 | -0.58 |
Net Debt / EBITDA Ratio | -2.43 | -2.50 | -1.58 | -2.13 | -2.06 | -2.26 |
Net Debt / FCF Ratio | -2.89 | -3.24 | -3.89 | -6.48 | -6.81 | -8.29 |
Asset Turnover | 0.54 | 0.56 | 0.58 | 0.52 | 0.83 | 0.78 |
Inventory Turnover | 6.26 | 5.88 | 5.58 | 5.37 | 7.59 | 7.36 |
Quick Ratio | 2.38 | 2.43 | 3.88 | 3.60 | 3.82 | 3.48 |
Current Ratio | 2.72 | 2.84 | 4.73 | 4.31 | 4.31 | 3.89 |
Return on Equity (ROE) | 3.24% | 3.00% | 10.22% | 6.75% | 21.88% | 23.96% |
Return on Assets (ROA) | 3.12% | 2.99% | 5.03% | 3.65% | 11.39% | 13.70% |
Return on Invested Capital (ROIC) | 6.95% | 6.19% | 10.98% | 9.70% | 40.17% | 59.42% |
Return on Capital Employed (ROCE) | 6.10% | 5.60% | 8.70% | 6.50% | 20.20% | 24.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.49% | 1.25% | 3.91% | 1.74% | 2.74% | 1.93% |
FCF Yield | 4.34% | 3.47% | 2.30% | 1.01% | 0.93% | 0.60% |
Dividend Yield | 0.91% | 0.81% | 2.56% | 1.49% | 0.30% | 1.03% |
Payout Ratio | 66.07% | 127.52% | 47.33% | 82.56% | 47.67% | 46.30% |
Buyback Yield / Dilution | -2.37% | -1.77% | 0.61% | -0.82% | 0.20% | -23.76% |
Total Shareholder Return | -1.46% | -0.96% | 3.17% | 0.68% | 0.50% | -22.73% |